08Jun 2023
Identification of covariates modulating B‐cell repopulation kinetics in subjects receiving rituximab treatment

Identification of covariates modulating B‐cell repopulation kinetics in subjects receiving rituximab treatment

This study examined the factors that influence B-cell repopulation in patients receiving rituximab, an anti-CD20 monoclonal antibody used in autoimmune diseases. The retrospective observational study analyzed data from 839 subjects who received 2,017 courses of rituximab. The study found that patient-specific factors such as age over 60, impaired kidney function, specific underlying diseases, and solid organ transplantation were associated with delayed B-cell repopulation. Additionally, co-immunosuppression with corticosteroids or azathioprine also prolonged B-cell recovery. The study suggests that adjusting rituximab dosing intervals may be beneficial for older patients or those with impaired kidney function, while caution is needed when using co-medications due to their impact on B-cell recovery.

  • #rheumatology

Like

Save

Share